This chemical is primarily utilized in pharmaceutical research and development, particularly in the synthesis of bioactive compounds. It serves as a key intermediate in the creation of potential drug candidates targeting neurological disorders, such as Parkinson's disease and Alzheimer's disease, due to its structural similarity to neurotransmitters. Additionally, it is explored for its potential in designing molecules with antipsychotic and antidepressant properties. Its versatile structure also makes it valuable in medicinal chemistry for optimizing drug efficacy and selectivity. Researchers often employ it in the development of novel therapeutic agents, leveraging its tetrahydropyrido-pyrazine core to enhance binding affinity and metabolic stability.